Search - tctmd.com

Displaying 1 - 20 of 177

Sort: Relevancy | Date

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

Presentation TCT 2019

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Serbia Presents: A Case of a Patient With Multiple Comorbidities in Setting Limited TAVR Resources

Presenter: Milan Nedeljkovic

September 28, 2019

News Opinion Off Script TCT 2019

Off Script: The New Gatekeepers of Procedural Education

Kwan S. Lee

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Medical Therapy Is Best!

Presenter: Freek Verheugt

September 28, 2019

Presentation TCT 2019

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

Presenter: Kishore Harjai

September 28, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

Reshaping Strategy During TAVR Procedures

Presenter: Mao Chen

September 27, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

Advertisement

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Predicting Final Valve Position After TAVR: Different Devices, Different Success

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Serbia Presents: A Case of a Patient With Multiple Comorbidities in Setting Limited TAVR Resources

Off Script: The New Gatekeepers of Procedural Education

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Medical Therapy Is Best!

Flash Debate: TAVR in the Moderate-Risk Bleeding Patient With AF ⁠— Close the LAA!

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Reshaping Strategy During TAVR Procedures

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Portico Noninferior to Commercial TAVR Valves in IDE Study

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content